Note: This article reflects market data and analyst estimates as of late September 2019. All figures are historical and should not be interpreted as current investment advice.
Splunk (NASDAQ: SPLK) – Market Activity Overview
Splunk (SPLK) attracted attention in late September 2019 when its trading volume aligned closely with its longer-term average of approximately 1.99 million shares per session. The stock opened at $121.35 during the session in question, posted an intraday gain of roughly 0.94%, and closed at $121.60. Its intraday range reached a low of $120.26, indicating relatively contained price movement within that session.
At the time, Splunk’s public float stood at approximately 150.65 million shares, with a market capitalisation reported at around $18.62 billion USD.
Splunk (SPLK) – Analyst Price Target
Sell-side consensus at the time pointed to a 12-month price target of approximately $150.55 for SPLK. Relative to the closing price of $121.60, this implied a potential upside of roughly 27%, which analysts interpreted as a broadly bullish signal for the stock at that moment in time.
Splunk (SPLK) – Technical Analysis
Two widely used momentum indicators — the Relative Strength Index (RSI) and Stochastic Oscillator — were cited in the analysis of SPLK at this time.
- Stochastic Oscillator: SPLK recorded a Stochastic reading of approximately 89.86%. A reading near 80 or above typically signals an overbought condition, though interpretation varies by analyst and time frame. The source characterised this reading as neither overbought nor oversold, which is a non-standard interpretation of a reading in that range.
- 200-Day Moving Average (200 MA): SPLK’s price position relative to its 200-day moving average was described as indicating bearish momentum, suggesting the stock was trading below or close to this key longer-term trend line.
Taken together, the technical picture for SPLK in this period was mixed: bullish from an analyst consensus standpoint, but with some caution warranted from longer-term moving average signals.
HealthEquity (NASDAQ: HQY) – Market Activity Overview
HealthEquity (HQY) recorded a trading volume of approximately 877,300 shares during the session, below its 100-day average of around 1.08 million shares. The stock opened at $60.89 and closed at $61.47, representing a gain of approximately 0.95% for the session.
HealthEquity (HQY) – Earnings Surprise
In the most recent quarterly earnings report at the time, HealthEquity posted EPS of $0.36, against a consensus estimate of $0.26 — a meaningful positive earnings surprise. Revenue growth came in at approximately +21.89% year-over-year for that reporting period. However, revenue growth had decelerated relative to the prior quarter, falling by approximately 13.99% quarter-over-quarter, indicating a slowdown in the growth rate even as the absolute figures remained positive.
HealthEquity (HQY) – Key Price and Volatility Metrics
The following technical and statistical metrics were cited for HQY around this period:
- 52-week low recovery: HQY had gained approximately 22.23% from its 52-week low of $50.29.
- 200-day moving average: The stock’s average price over the prior 200 days was approximately $68.49, and HQY was trading at a discount of roughly 10.40% to that level.
- 50-day moving average deviation: The stock was approximately 9.23% below its 50-day moving average, indicating near-term bearish positioning.
- Price volatility (30-day): Approximately 4.62%.
- Price volatility (7-day): Approximately 2.68%.
- 5-day performance: HQY lost approximately 0.93% over the prior five trading sessions.
- 12-month performance: HQY gained approximately 3.05% over the prior 12-month period.
HealthEquity (HQY) – Analyst Consensus and Price Target
According to a Barchart consensus rating cited in the original source, HealthEquity’s rating moved from 4.82 to 4.70 during the month — described as an improvement on that rating scale. The analyst consensus 12-month price target was cited at $61.47 per share, which at the time of the snapshot essentially mirrored the then-current trading price, implying negligible expected upside from the consensus view. However, the high-end analyst target was reported as significantly above the current price, with the stock trading at roughly a 35.29% discount to that optimistic high-end estimate.
Context for DevOps and Technology Investors
Splunk is a well-known platform in the DevOps and IT operations space, providing machine data analytics, log management, and security information event management (SIEM) capabilities. Movements in SPLK stock are sometimes watched by technology practitioners as a proxy for enterprise spending on observability and data analytics tooling.
HealthEquity operates in the health savings account (HSA) administration space and is less directly connected to DevOps toolchains, though it operates significant cloud-based financial services infrastructure.
All data in this article reflects reported figures from approximately September 2019. Readers should consult current financial data sources for up-to-date information before making any investment decisions.